Literature DB >> 15850844

Glucocorticoid resistance and hypersensitivity.

Carl D Malchoff1, Diana M Malchoff.   

Abstract

This article emphasizes the disorders caused by mutations and polymorphisms of the alpha form of the glucocorticoid receptor. These disorders usually present with increased circulating cortisol concentrations and must be distinguished from Cushing's syndrome, because the therapies are markedly different. The other disorders present with clinical features limited to a specific organ system. Although they illustrate important physiologic and pathophysiologic principles, they usually are not confused with Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850844     DOI: 10.1016/j.ecl.2005.02.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  4 in total

1.  Osteonecrosis of the hip after short courses of oral and inhaled steroids in a child with an increased number of glucocorticoid receptors.

Authors:  Ilenia Drigo; Alessia Saccari; Egidio Barbi; Fiora Bartoli; Giuliana Decorti; Alessandro Ventura
Journal:  Eur J Pediatr       Date:  2006-06-17       Impact factor: 3.183

Review 2.  Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia.

Authors:  Hershel Raff; Susmeeta T Sharma; Lynnette K Nieman
Journal:  Compr Physiol       Date:  2014-04       Impact factor: 9.090

3.  A novel human glucocorticoid receptor SNP results in increased transactivation potential.

Authors:  Tajia L Green; Kelly Tung; Debora Lim; Stacey M Leventhal; Kiho Cho; David G Greenhalgh
Journal:  Biochem Biophys Rep       Date:  2016-12-18

4.  A Case of Glucocorticoid Hypersensitivity Syndrome Associated With Underlying Rubella Virus Infection.

Authors:  Zhen Zhang; Ying Feng; Yang Cao; Yan Chen; Fangping Li
Journal:  AACE Clin Case Rep       Date:  2021-06-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.